Fig. 6
From: Antitumor activity of rucaparib plus PLX038A in serous endometrial carcinoma
Immunofluorescence staining of DNA damage markers in PH537. Cells were treated with either vehicle, rucaparib, SN-38, or the combination. Foci were labeled with green fluorescence: (A) gamma H2AX (phospho-Ser139-H2A.X) or (B) RAD51. Nuclei were stained blue (DAPI)